Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000899923-23-000038
Filing Date
2023-06-01
Accepted
2023-06-01 16:02:01
Documents
6
Effectiveness Date
2023-06-01

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8mygn_june2023.htm S-8 64737
2 EX-FILING FEES mygn-ex107toformsx8_2023.htm EX-FILING FEES 18707
3 EX-5.1 ex-51mintzopiniontosx8_2023.htm EX-5.1 8752
4 EX-23.1 mygns-8xex231consent_2023.htm EX-23.1 2383
5 EX-99.1 a2017employeedirectorconsu.htm EX-99.1 85318
6 picture1.jpg GRAPHIC 8690
  Complete submission text file 0000899923-23-000038.txt   192954
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272327 | Film No.: 23984621
SIC: 2835 In Vitro & In Vivo Diagnostic Substances